{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:56:31Z","timestamp":1787068591995,"version":"build-2736575974"},"reference-count":44,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":322,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>UK guidance on the assessment and management of thyroid disease was set out in NICE guideline NG145 in 2019 and is expected to result in an increase in radioactive iodine (RAI) being offered as a first-line definitive treatment for hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>In this work we analyse longitudinal UK Biobank data to assess all-cause mortality and comorbidity risks associated with the main treatment modalities for 793 participants with hyperthyroidism, specifically antithyroid drugs (ATDs), RAI and thyroidectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants treated with RAI showed reduced all-cause mortality compared with those treated with ATD alone (time to event ratio: 1.8, 95% CI: 0.9\u20133.6), albeit the result did not reach statistical significance, as did those treated by thyroidectomy (time ratio: 2.0, 95% CI: 1.1\u20133.9). For treated patients, odds ratios were generally elevated for osteoporosis, cardiovascular events and atrial fibrillation, but again did not reach statistical significance except for those patients treated by ATDs, with an odds ratio for atrial fibrillation of 2.2 (95% CI: 1.2\u20134.1) versus controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings were consistent with those previously reported in the literature and do not reveal any evidence from the UK Biobank to contradict the safety of RAI being offered as a first-line treatment. The data are also suggestive, however, that treatments do not fully eliminate risks of complications related to hyperthyroidism. This reinforces the need for both clear communication where there may be risks of complications such as osteoporosis as well as clinical support for patients even after definitive treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-24-0393","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T09:47:31Z","timestamp":1743587251000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":5,"title":["Variable hyperthyroidism outcomes related to different treatment regimens: an analysis of UK Biobank data"],"prefix":"10.1530","volume":"14","author":[{"given":"Kris","family":"Elomaa","sequence":"first","affiliation":[{"name":"School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey 1 , ,","place":["Guildford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-6511","authenticated-orcid":true,"given":"Matt","family":"Spick","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey 1 , ,","place":["Guildford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earn H","family":"Gan","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, International Centre for Life, Newcastle University 2 , ,","place":["Newcastle upon Tyne, UK"]},{"name":"Department of Endocrinology, Translational and Clinical Research Institute, Newcastle University 3 , ,","place":["Newcastle upon Tyne, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-8063","authenticated-orcid":true,"given":"Simon H","family":"Pearce","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Translational and Clinical Research Institute, Newcastle University 3 , ,","place":["Newcastle upon Tyne, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2956-6676","authenticated-orcid":true,"given":"Nophar","family":"Geifman","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey 1 , ,","place":["Guildford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2026070712541933500_bib1","first-page":"363","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"93","author":"Kravets","year":"2016","journal-title":"AFP"},{"key":"2026070712541933500_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"2026070712541933500_bib3","volume-title":"Endotext","author":"Toro-Tobon"},{"key":"2026070712541933500_bib4","doi-asserted-by":"crossref","first-page":"g5128","DOI":"10.1136\/bmj.g5128","article-title":"Diagnosis and management of thyrotoxicosis","volume":"349","author":"Vaidya","year":"2014","journal-title":"BMJ"},{"key":"2026070712541933500_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"2026070712541933500_bib6","doi-asserted-by":"crossref","first-page":"R241","DOI":"10.1530\/EJE-14-0047","article-title":"Mechanisms in endocrinology: autoimmune thyroid disease: old and new players","volume":"170","author":"Effraimidis","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2026070712541933500_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM199406163302407","article-title":"The management of hyperthyroidism","volume":"330","author":"Wood","year":"1994","journal-title":"N Engl J Med"},{"key":"2026070712541933500_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.1946.02870190010003","article-title":"The treatment of hyperthyroidism with radioactive iodine","volume":"131","author":"Chapman","year":"1946","journal-title":"JAMA"},{"key":"2026070712541933500_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419844523","article-title":"Considerations for thyroidectomy as treatment for Graves disease","volume":"12","author":"Smithson","year":"2019","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"2026070712541933500_bib10","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1007\/s00330-023-09620-1","article-title":"Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent\/relapsed Graves\u2019 disease, a pilot study","volume":"33","author":"Fung","year":"2023","journal-title":"Eur Radiol"},{"key":"2026070712541933500_bib11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/thy.2018.0320","article-title":"Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk","volume":"29","author":"Lillevang-Johansen","year":"2019","journal-title":"Thyroid"},{"key":"2026070712541933500_bib12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"2026070712541933500_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/JOE-12-0059","article-title":"The skeletal consequences of thyrotoxicosis","volume":"213","author":"Nicholls","year":"2012","journal-title":"J Endocrinol"},{"key":"2026070712541933500_bib14","article-title":"National Institute for Health and Care Excellence (NICE) Overview | thyroid disease: assessment and management | guidance"},{"key":"2026070712541933500_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bmj.313.7056.539","article-title":"Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology","volume":"313","author":"Vanderpump","year":"1996","journal-title":"BMJ"},{"key":"2026070712541933500_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.hlpt.2012.07.003","article-title":"UK Biobank: current status and what it means for epidemiology","volume":"1","author":"Allen","year":"2012","journal-title":"Health Policy Technology"},{"key":"2026070712541933500_bib17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamainternmed.2019.0981","article-title":"Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism","volume":"179","author":"Kitahara","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2026070712541933500_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25072","article-title":"Cancer risk after radioactive iodine treatment for hyperthyroidism","volume":"4","author":"Shim","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026070712541933500_bib19","article-title":"OPCS classification of interventions and procedures \u2013 NHS data standards directory \u2013 opcs-classification-of-interventions-and-procedures"},{"key":"2026070712541933500_bib20","article-title":"UK Biobank"},{"key":"2026070712541933500_bib21","article-title":"UK Biobank"},{"key":"2026070712541933500_bib22","article-title":"UK Biobank biomarker data"},{"key":"2026070712541933500_bib23","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team"},{"key":"2026070712541933500_bib24","article-title":"UK Biobank. Index of multiple deprivation: data-field 26410"},{"key":"2026070712541933500_bib25","article-title":"UK Biobank. Indices of multiple deprivation: category 76"},{"key":"2026070712541933500_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0904","article-title":"MACE and hyperthyroidism treated with medication, radioactive iodine, or thyroidectomy","volume":"7","author":"Peng","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026070712541933500_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","article-title":"Primary therapy of Graves\u2019 disease and cardiovascular morbidity and mortality: a linked-record cohort study","volume":"7","author":"Okosieme","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070712541933500_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad114.2053","article-title":"OR26-05 long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: EGRET study","volume":"7","author":"Torlinska","year":"2023","journal-title":"J Endocr Soc"},{"key":"2026070712541933500_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.mayocp.2022.12.013","article-title":"Incidence, risk factors, and outcomes of incident atrial fibrillation in patients with Graves disease","volume":"98","author":"Naser","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"2026070712541933500_bib30","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/sj.bjc.6605624","article-title":"Cancer risk in patients hospitalised for Graves\u2019 disease: a population-based cohort study in Sweden","volume":"102","author":"Shu","year":"2010","journal-title":"Br J Cancer"},{"key":"2026070712541933500_bib31","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/ERC-12-0219","article-title":"Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective","volume":"20","author":"Moeller","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"2026070712541933500_bib32","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0181","article-title":"Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study","volume":"13","author":"Riis","year":"2024","journal-title":"Eur Thyroid J"},{"key":"2026070712541933500_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.apergo.2004.01.002","article-title":"Understanding statistical power in the context of applied research","volume":"35","author":"Baguley","year":"2004","journal-title":"Appl Ergon"},{"key":"2026070712541933500_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100302","article-title":"Observations from statistical review editors: a commentary","volume":"4","author":"Spick","year":"2024","journal-title":"JID Innov"},{"key":"2026070712541933500_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"key":"2026070712541933500_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2006.08.042","article-title":"Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy","volume":"49","author":"Osman","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026070712541933500_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/2230-8210.93737","article-title":"Interactions between thyroid disorders and kidney disease","volume":"16","author":"Basu","year":"2012","journal-title":"Indian J Endocr Metab"},{"key":"2026070712541933500_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-90-2-164","article-title":"Alkaline phosphatase isoenzyme patterns in hyperthyroidism","volume":"90","author":"Cooper","year":"2008","journal-title":"Ann Intern Med"},{"key":"2026070712541933500_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0002-9610(86)90435-6","article-title":"Post-thyroidectomy hypocalcemia: incidence and risk factors","volume":"152","author":"Wingert","year":"1986","journal-title":"Am J Surg"},{"key":"2026070712541933500_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014455","article-title":"Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia: a meta-analysis","volume":"98","author":"Xing","year":"2019","journal-title":"Medicine"},{"key":"2026070712541933500_bib41","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"2026070712541933500_bib42","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and Co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"2026070712541933500_bib43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jc.2018-01738","article-title":"Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves disease","volume":"104","author":"Bano","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712541933500_bib44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/thy.2018.0315","article-title":"Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves\u2019 hyperthyroidism: a long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-Item short form health status survey","volume":"29","author":"T\u00f6rring","year":"2019","journal-title":"Thyroid"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/2\/ETJ-24-0393.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/2\/ETJ-24-0393.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0393\/36946\/etj-24-0393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-24-0393\/36946\/etj-24-0393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:22:24Z","timestamp":1783444944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/2\/e240393\/4484\/Variable-hyperthyroidism-outcomes-related-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-24-0393","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"article-number":"e240393"}}